Related Experiment Video
Updated: Jul 13, 2026
13:19
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Adjuvant biologic therapy for breast cancer
Barbara S Craft1, Gabriel N Hortobagyi, Stacy L Moulder
1Division of Hematology and Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
Cancer Journal (Sudbury, Mass.)
|July 11, 2007
Summary
Biologic therapy, a targeted approach, is evolving for breast cancer treatment. This review covers adjuvant studies and future directions for biotherapy in managing breast cancer.
Area of Science:
- Oncology
- Pharmacology
Background:
- Breast cancer remains a significant health concern despite declining mortality.
- Advances in understanding cell biology and signaling pathways drive evolution in breast cancer drug therapy.
- Targeted agents offer improved efficacy and tolerability for breast cancer treatment.
Purpose of the Study:
- To review the results of adjuvant biologic therapy studies for breast cancer.
- To discuss future directions in breast cancer biotherapy.
Main Methods:
- Review of recent adjuvant breast cancer studies.
- Analysis of biologic therapy's role in targeted treatment.
Main Results:
- Biologic therapy is a cornerstone for advanced breast cancer and is expanding into adjuvant settings.
- Several adjuvant studies have demonstrated the potential of biotherapy.
Conclusions:
- Biologic therapy represents a promising avenue for breast cancer treatment, with ongoing research exploring its adjuvant applications.
- Future directions in breast cancer biotherapy involve further refinement of targeted agents and their integration into treatment protocols.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...